NCT02492958 - SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults | Biotech Hunter

Enrollment

136

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Staphylococcal Infections

Interventions

BIOLOGICAL

Staphylococcus aureus 4-antigen vaccine

a single 0.5 mL dose of investigational product into the deltoid muscle in the upper arm

BIOLOGICAL

Placebo

a single 0.5 mL dose of investigational product into the deltoid muscle in the upper arm

Trial Locations (2)

SOUSEIKAI Sumida Hospital (formerly Medical Co. LTA Sumida Hospital), Sumida-ku

SOUSEIKAI PS Clinic (formerly Medical Co. LTA PS Clinic), Fukuoka